logo
logo
Sign in

Global Helicobacter Pylori Diagnostics Market Size, Status and Forecast 2021-2027

avatar
vivek bajaj
Global Helicobacter Pylori Diagnostics Market Size, Status and Forecast 2021-2027

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations.

One of the key drivers witnessed in the market is the growing cost-effectiveness of diagnosis and personalized antibiotic therapy. H. pylori bacteria causes ulcer. H. pylori infection requires antibiotic therapy that includes 10-14 days treatment regimen. This treatment regimen comprises of one or two antibiotics such as amoxicillin, tetracycline, metronidazole, or clarithromycin in combination with ranitidine bismuth citrate, bismuth subsalicylate, and a proton pump inhibitor (PPI). Ulcer-related symptoms such as abdominal pain and nausea and inflammation of gastric mucosa can be cured using PPIs or H2 blockers in combination with antibiotics. The cost-effectiveness of antibiotics and the lesser duration of treatment boosts the adoption of antibiotic regimen by healthcare professionals. This in turn, will drive the demand for pre- and post-monitoring tests.

 

 

In terms of geography, the Europe accounted for the majority market shares during 2017 and this mainly accounted to the growing prevalence of peptic ulcer disease and gastritis. The increasing patient pool looking for the early detection of symptoms and treatment is boosting the demand for helicobacter pylori diagnostics in the region. Owing to the continuous efforts of vendors to develop a vaccination for H. pylori infection and the introduction of improved diagnostic techniques, the market will continue to witness considerable growth in this region during the next four years as well.

 

 

The helicobacter pylori diagnostics market is characterized by the presence of major vendors and is highly competitive. These vendors compete against each other based on factors including pricing, product differentiation, and advancements in technology. Vendors are highly focusing on expanding their product portfolio and increasing investments in acquiring other players, which will help them increase their revenue shares. Additionally, they are also focusing on the development of vaccines and enhancing their presence in the regional and untapped markets.

 

Hospitals and clinics reduce the overall disease burden and promote health by offering immunoassays and molecular diagnostic techniques. These techniques enable the early diagnosis of infectious and lethal diseases. The patient pool suffering from infectious diseases such as bacterial diseases (enteric bacteria), cancer, and other life-threatening diseases highly rely on hospitals since they have tie-ups with research and developmental centers and research institutes.

 

Market Analysis and Insights: Global Helicobacter Pylori Diagnostics Market

The global Helicobacter Pylori Diagnostics market size is projected to reach US$ 976.2 million by 2027, from US$ 596.2 million in 2020, at a CAGR of 7.3% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Helicobacter Pylori Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Helicobacter Pylori Diagnostics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Helicobacter Pylori Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Helicobacter Pylori Diagnostics market.

 

Global Helicobacter Pylori Diagnostics Scope and Market Size

Helicobacter Pylori Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Helicobacter Pylori Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

 

Segment by Type

 

  • Invasive Techniques
  • Non-invasive Techniques

 

Segment by Application

 

  • Hospitals and Clinics
  • Diagnostic Laboratories

 

By Region

 

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

 

By Company

 

  • Sekisui Diagnostics
  • F. Hoffmann-La Roche
  • Medline Industries
  • Meridian Bioscience
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Alpha Laboratories
  • EKF Diagnostics
  • Quidel
  • Halyard Health
  • Cardinal Health
  • Beckman Coulter
  • Agilent Technologies
  • Coris BioConcept


Table of content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Invasive Techniques
1.2.3 Non-invasive Techniques
1.3 Market by Application
1.3.1 Global Helicobacter Pylori Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Helicobacter Pylori Diagnostics Market Perspective (2016-2027)
2.2 Helicobacter Pylori Diagnostics Growth Trends by Regions
2.2.1 Helicobacter Pylori Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Helicobacter Pylori Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Helicobacter Pylori Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Helicobacter Pylori Diagnostics Industry Dynamic
2.3.1 Helicobacter Pylori Diagnostics Market Trends
2.3.2 Helicobacter Pylori Diagnostics Market Drivers
2.3.3 Helicobacter Pylori Diagnostics Market Challenges
2.3.4 Helicobacter Pylori Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Helicobacter Pylori Diagnostics Players by Revenue
3.1.1 Global Top Helicobacter Pylori Diagnostics Players by Revenue (2016-2021)
3.1.2 Global

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/

collect
0
avatar
vivek bajaj
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more